Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A Texas woman whose husband died from pancreatic cancer in July has filed a lawsuit blaming the type-2 diabetes drug Janumet for the causing the condition that cost him his life.
William Kryzak of Texas was diagnosed with pancreatic cancer in September 2012. For two years prior to this diagnosis, William was prescribed and taking Janumet, according to a Janumet pancreatic cancer lawsuit filed by his wife. Just months before his diagnosis of pancreatic cancer, Kryzak quit taking Janumet.
He died in July. His wife, Paula, filed the Janumet lawsuit alleging his wrongful death.
Kryzak’s Janumet pancreatic cancer lawsuit has joined thousands of other type-2 diabetes drug lawsuits in a type of coordinated group lawsuit called a multidistrict litigation, or MDL. In MDLs, a group of lawsuits with similar allegations are tried together under one judge. Other type-2 diabetes medications alleged to cause pancreatic cancer after prolonged use include Victoza, Byetta, and Januvia.
All of the type-2 diabetes medications fall under a category of drugs known as incretin mimetics. Medical studies such as pre-clinical trials performed by Merck before its market approval of Janumet allegedly show evidence of patients being at an increased risk of developing pancreatic cancer.
Despite these pre-clinical studies, there are no warning labels on Janumet informing patients of these increased risks.
The multidistrict litigation, created because of the volume of Janumet lawsuits, indicates a strong possibility that a Janumet class action lawsuit will be formed. With a Janumet class action lawsuit, a group of plaintiffs with similar Janumet allegations can file a lawsuit on behalf of their group, or Class. Should any settlement be reached, the Class of affected victims share in the settlement with the attorneys being paid via a settlement fund. Since attorneys are only compensated upon a settlement, a Janumet class action lawsuit may be seen as advantageous for affected victims to consider.
The Janumet Pancreatic Cancer Lawsuit is Paula and William Kryzak v. Merck Sharp and Dohme Co., Case 3:14-cv-02020-AJB-MDD, in the Southern District of California.
In general, Janumet pancreatic cancer lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Januvia, Janumet, Byetta, Victoza Cancer Class Action Lawsuit Investigation
If you or your loved one took Januvia, Victoza, Janumet or Byetta and were diagnosed with pancreatic cancer or thyroid cancer, you have a legal claim. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
